Clinic taps growing demand for personalized heal
Author: Michael
New $400 million initiative will combine human b
C2N Diagnostics has formed a collaboration with S
Voyager Therapeutics announced FDA clearance of i
Eccogene and AstraZeneca will present multiple cl
Augustine Therapeutics will present a late-breaki
Corsair Pharma completed a first-in-human phase 1
NanoDetection Technology and Oligomerix have exec
HeartSciences launched MyoVista Insights version
Australian regulators clear Scribe Therapeutics